A scientific research from January 2019 that assessed the outcome of the dopamine precursor (levodopa), dopamine antagonist (risperidone), and a placebo on reward responses to new music – such as the diploma of satisfaction experienced through musical chills, as measured by variations in electrodermal activity and subjective scores – identifi